Could a common prostate drug ease lewy body dementia?
NCT ID NCT04760860
First seen Mar 15, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This early-stage trial tests whether terazosin, a drug currently used for prostate issues, is safe and tolerable for people with dementia with Lewy bodies. Forty participants will be randomly assigned to receive either terazosin or a placebo. The study focuses on side effects and how well people stick with the treatment, while also checking for changes in brain energy levels and movement symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa
Iowa City, Iowa, 52252, United States
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.